230 related articles for article (PubMed ID: 17304721)
1. [Polymorphisms in the genes of cytochrome oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoprotein E (APOE) as risk factors for Parkinson's disease].
Durić G; Svetel M; Nikolaevic SI; Dragadević N; Gavrilović J; Kostić VS
Vojnosanit Pregl; 2007 Jan; 64(1):25-30. PubMed ID: 17304721
[TBL] [Abstract][Full Text] [Related]
2. Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism.
Bon MA; Jansen Steur EN; de Vos RA; Vermes I
Neurosci Lett; 1999 May; 266(2):149-51. PubMed ID: 10353349
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease.
Maraganore DM; Farrer MJ; Hardy JA; McDonnell SK; Schaid DJ; Rocca WA
Mov Disord; 2000 Jul; 15(4):714-9. PubMed ID: 10928584
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease, CYP2D6 polymorphism, and age.
Payami H; Lee N; Zareparsi S; Gonzales McNeal M; Camicioli R; Bird TD; Sexton G; Gancher S; Kaye J; Calhoun D; Swanson PD; Nutt J
Neurology; 2001 May; 56(10):1363-70. PubMed ID: 11376189
[TBL] [Abstract][Full Text] [Related]
5. The role of PON1 and CYP2D6 genes in susceptibility to organophosphorus chronic intoxication in Egyptian patients.
Tawfik Khattab AM; Zayed AA; Ahmed AI; AbdelAal AG; Mekdad AA
Neurotoxicology; 2016 Mar; 53():102-107. PubMed ID: 26723569
[TBL] [Abstract][Full Text] [Related]
6. Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
Tanhapour M; Miri A; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Pourmotabbed T; Shakiba E
Clin Rheumatol; 2018 Apr; 37(4):971-977. PubMed ID: 29273831
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.
Feldman B; Chapman J; Korczyn AD
Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease.
Bialecka M; Klodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Safranow K; Droździk M
Parkinsonism Relat Disord; 2007 May; 13(4):224-9. PubMed ID: 17270484
[TBL] [Abstract][Full Text] [Related]
9. CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia.
Gołab-Janowska M; Honczarenko K; Gawrońska-Szklarz B; Potemkowski A
Neurol Neurochir Pol; 2007; 41(2):113-21. PubMed ID: 17530572
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
Parsian A; Racette B; Goldsmith LJ; Perlmutter JS
Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase-2 with Parkinson's disease.
Singh M; Khanna VK; Shukla R; Parmar D
Dis Markers; 2010; 28(2):87-93. PubMed ID: 20364044
[TBL] [Abstract][Full Text] [Related]
13. Interaction between GSTM1-null and CYP2D6-deficient alleles in the pathogenesis of Parkinson's disease.
Santt O; Baranova H; Albuisson E; Bignon YJ; Lucotte G
Eur J Neurol; 2004 Apr; 11(4):247-51. PubMed ID: 15061826
[TBL] [Abstract][Full Text] [Related]
14. CYP2D6 polymorphism and Parkinson's disease susceptibility.
Sabbagh N; Brice A; Marez D; Dürr A; Legrand M; Lo Guidice JM; Destée A; Agid Y; Broly F
Mov Disord; 1999 Mar; 14(2):230-6. PubMed ID: 10091614
[TBL] [Abstract][Full Text] [Related]
15. CYP2D6 allelic frequencies in young-onset Parkinson's disease.
Sandy MS; Armstrong M; Tanner CM; Daly AK; Di Monte DA; Langston JW; Idle JR
Neurology; 1996 Jul; 47(1):225-30. PubMed ID: 8710083
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease.
Kondo I; Yamamoto M
Brain Res; 1998 Sep; 806(2):271-3. PubMed ID: 9739148
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E polymorphisms and Parkinson's disease.
Oliveri RL; Nicoletti G; Cittadella R; Manna I; Branca D; Zappia M; Gambardella A; Caracciolo M; Quattrone A
Neurosci Lett; 1999 Dec; 277(2):83-6. PubMed ID: 10624815
[TBL] [Abstract][Full Text] [Related]
18. Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease.
Vilar R; Coelho H; Rodrigues E; Gama MJ; Rivera I; Taioli E; Lechner MC
Eur J Neurol; 2007 Feb; 14(2):156-61. PubMed ID: 17250723
[TBL] [Abstract][Full Text] [Related]
19. Role of PON1 L55M Gene Polymorphism in Parkinson's Disease among North Indian Population.
Kumar B; Saluja A; Juneja A; Anand KS; Saraswathy KN; Longkumer I; Dhamija RK
Neurol India; 2024 Mar; 72(2):364-367. PubMed ID: 38691483
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase 1 Met--Leu 54 polymorphism is associated with Parkinson's disease.
Akhmedova SN; Yakimovsky AK; Schwartz EI
J Neurol Sci; 2001 Mar; 184(2):179-82. PubMed ID: 11239953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
